Although integrin/JNK/c-JUN pathway contributes to higher matrix stiffness-upregulated LOXL2 in HCC cells, we are still unable to exclude the activation of other signal pathways in this regulating process. The gene discussed is LOXL2; the disease is hepatocellular carcinoma.